PreComb Therapeutics
PrivateLast Round
Series A
Dec 30, 2024
Total Funding Raised
$3.73M
Company Overview
PreComb Therapeutics operates in Healthcare & Life Sciences and is based in Hombrechtikon. Its latest recorded funding round was a Series A round in December 2024.
PreComb Therapeutics is a biotechnology company that develops 3D microtumor-based drug testing platforms to enable personalized cancer therapy and drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreComb Therapeutics Comparables
Compare PreComb Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 2cureX | 83% | |
| First Ascent Biomedical | 82% | |
| Kiyatec | 81% |
For institutional investors. Book with your work email.
PreComb Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 30, 2024 | ||||
| Seed | Oct 4, 2022 | ||||
| Seed | Apr 28, 2021 |
For institutional investors. Book with your work email.
PreComb Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Koodos | Series A |
| LongeVC | Seed |
| Kinled Holding | Seed |
| High-Tech Gründerfonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 369% MoM.
- Mar 1, 2026
Monthly visitors grew 124% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
PreComb Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PreComb Therapeutics's valuation, stock price, and market status.
Is PreComb Therapeutics a public or private company?
PreComb Therapeutics is a private company.
What is the current stock price of PreComb Therapeutics?
PreComb Therapeutics is a private company, so its shares have no public market price. Caplight tracks PreComb Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PreComb Therapeutics worth (valuation)?
Valuation information for PreComb Therapeutics is not publicly available.
Can I buy PreComb Therapeutics stock?
PreComb Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PreComb Therapeutics's last funding round?
PreComb Therapeutics's most recent funding round was Series A on December 30, 2024.
Who are the main investors in PreComb Therapeutics?
Key investors in PreComb Therapeutics include Koodos, Kinled Holding, High-Tech Gründerfonds.
Will PreComb Therapeutics IPO soon?
No public IPO plans have been announced for PreComb Therapeutics.
How can I track PreComb Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in PreComb Therapeutics's shares on secondary markets.